These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 320630)

  • 1. The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients.
    Csapo AI; Pulkkinen MO; Henzl MR
    Prostaglandins; 1977 Jan; 13(1):193-9. PubMed ID: 320630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of dysmenorrhea with naproxen sodium: a report on two independent double-blind trials.
    Henzl MR; Buttram V; Segre EJ; Bessler S
    Am J Obstet Gynecol; 1977 Apr; 127(8):818-23. PubMed ID: 322491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of inhibitors of prostaglandin synthesis in primary dysmenorrhea studied with hysterometry.
    Joelsson I; Lalos O
    Acta Obstet Gynecol Scand Suppl; 1979; 87():45-49. PubMed ID: 380251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.
    Lundström V; Gréen K; Svanborg K
    Acta Obstet Gynecol Scand Suppl; 1979; 87():51-6. PubMed ID: 111466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of uterine activity by prostaglandin synthetase inhibitors.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1979; 87():39-43. PubMed ID: 111465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naproxen and naproxen sodium in dysmenorrhea: development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy.
    Henzl MR; Izu A
    Acta Obstet Gynecol Scand Suppl; 1979; 87():105-17. PubMed ID: 380249
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I; Hedner N; Mannheimer C
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):123-9. PubMed ID: 8296814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients.
    Pulkkinen MO; Csapo AI
    Prostaglandins; 1978 Jun; 15(6):1055-62. PubMed ID: 358295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen.
    Lalos O; Nilsson B
    Int J Gynaecol Obstet; 1983 Feb; 21(1):33-7. PubMed ID: 6133791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I; Andersch B; Sundell G
    Acta Obstet Gynecol Scand; 1988; 67(8):711-6. PubMed ID: 3074603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhoea.
    Milsom I; Andersch B
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1129-35. PubMed ID: 6388624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.
    Hanson FW; Izu A; Henzl MR
    Obstet Gynecol; 1978 Nov; 52(5):583-7. PubMed ID: 364357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
    Henzl MR; Ortega-Herrera E; Rodriguez C; Izu A
    Am J Obstet Gynecol; 1979 Oct; 135(4):455-60. PubMed ID: 484644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative.
    Lundström V
    Acta Obstet Gynecol Scand; 1978; 57(5):421-8. PubMed ID: 103358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine "jet-washings" in dysmenorrheic women.
    Pulkkinen MO; Henzl MR; Csapo AI
    Prostaglandins; 1978 Mar; 15(3):543-50. PubMed ID: 351717
    [No Abstract]   [Full Text] [Related]  

  • 17. Naproxen, aspirin, and codeine in postpartum uterine pain.
    Bloomfield SS; Barden TP; Mitchell J
    Clin Pharmacol Ther; 1977 Apr; 21(4):414-21. PubMed ID: 321177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rationale for the treatment of dysmenorrhea.
    Csapo AI
    J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea.
    Oladosu FA; Tu FF; Farhan S; Garrison EF; Steiner ND; Roth GE; Hellman KM
    Am J Obstet Gynecol; 2018 Jul; 219(1):91.e1-91.e7. PubMed ID: 29733841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
    Cady RK; Diamond ML; Diamond MP; Ballard JE; Lener ME; Dorner DP; Derosier FJ; McDonald SA; White J; Runken MC
    Headache; 2011 May; 51(5):664-73. PubMed ID: 21521204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.